About MiNA Therapeutics
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
|
|
|
11-50 employees
View all MiNA Therapeutics employees
|
|
Biotechnology Research
|
|
$10M–$50M
|
|
+44 20 1234 5678
|
|
Translation & Innovation Hub, 80 Wood Lane, London, GB
|
|
2008
|
|
Drug Discovery, Liver Disease, Rna Therapeutics, Gene Activation
|
MiNA Therapeutics Alternatives
Frequently Asked Questions about MiNA Therapeutics
Robert Habib is the CEO of MiNA Therapeutics. To contact Robert Habib email at [email protected] or [email protected].
The decision makers in MiNA Therapeutics are Brid Ryan, Brid Ryan, Luke Haslett, etc. Click to Find MiNA Therapeutics decision makers emails.
MiNA Therapeutics headquarters is located at Translation & Innovation Hub, 80 Wood Lane, London, GB.
MiNA Therapeutics generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact MiNA Therapeutics by calling +44 20 1234 5678.
MiNA Therapeutics Staff Directory
Search MiNA Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
